Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Pudjiadi & Sons Tbk. (PNSE) Price & Performance

Diagnos Laboratorium Utama Tbk.Trade
Pudjiadi & Sons Tbk.Trade

Price performance (Past 24H)

Key statistics

Diagnos Laboratorium Utama Tbk. vs Pudjiadi & Sons Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 308B, 42.6K 24h volume), while Pudjiadi & Sons Tbk. trades at Rp500 (market cap 398.91B, 7.5K 24h volume). The key difference: Pudjiadi & Sons Tbk. is the larger of the two by market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (42.6K versus 7.5K). Which is the better fit depends on your goals.

DGNSPNSE
Market Cap
308B398.91B
Volume
42.6K7.5K
Lot
42675
Turnover
9.61M3.75M
Average Price
225.66500.47
Value
9.61M3.75M
Indicative Equilibrium Price
230515
Indicative Equilibrium Volume
1102

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DGNS
View details
PNSE
View details

About Diagnos Laboratorium Utama Tbk.

PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.

Read more on DGNS

About Pudjiadi & Sons Tbk.

PT Pudjiadi and Sons Tbk was established based on Notarial Deed No. 34 dated December 17, 1970 of Ridwan Suselo, s.h., notaris in Jakarta. Hotel business with all the facilities and infrastructures, such as , accommodation, office, shopping mall, apartment, recreation place and entertainment in the location of hotel. The Company is the owner of Jayakarta Hotel, a four star hotel.

Read more on PNSE